ArticleScientific reports2023

Structure based virtual screening and molecular simulation study of FDA-approved drugs to inhibit human HDAC6 and VISTA as dual cancer immunotherapy.

Muhammad Shahab et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.